External broker reports(aggregated public sources), Prabhudas Lilladhar

Prabhudas Lilladhar

Prabhudas Lilladher is one of India's leading research based financial services organisation.  

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Prabhudas Lilladher is one of India's leading research based financial services organisation.

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Krishna Institute of Medical Sciences / Equity Bottom-Up

Krishna Institute of Medical Sciences (KIMS IN)

<ul><li>Krishna Institute of Medical Sciences (KIMS) reported EBITDA growth of 27% YoY, adj for one time write offs (Rs80-90mn); EBITDA was largely in line with our estimates.</li><li>Our FY26E/FY27E EBITDA stands increased by 2-5% as we factor in new bed addition.</li><li>New leadership team hiring across Karnataka and Kerala cluster provides comfort for faster ramp up in these clusters.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Krishna Institute of Medical Sciences (KIMS) reported EBITDA growth of 27% YoY, adj for one time write offs (Rs80-90mn); EBITDA was largely in line with our estimates.Our FY26E/FY27E EBITDA stands increased by 2-5% as we factor in new bed addition.New leadership team hiring across Karnataka and Kerala cluster provides comfort for faster ramp up in these clusters.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Krishna Institute of Medical Sciences - Growth Intact Despite Aggressive Expansion Plan